Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Am J Hum Genet ; 90(2): 340-6, 2012 Feb 10.
Artículo en Inglés | MEDLINE | ID: mdl-22265016

RESUMEN

Tylosis esophageal cancer (TOC) is an autosomal-dominant syndrome characterized by palmoplantar keratoderma, oral precursor lesions, and a high lifetime risk of esophageal cancer. We have previously localized the TOC locus to a small genomic interval within chromosomal region 17q25. Using a targeted capture array and next-generation sequencing, we have now identified missense mutations (c.557T>C [p.Ile186Thr] and c.566C>T [p.Pro189Leu] in RHBDF2, which encodes the inactive rhomboid protease RHBDF2 (also known as iRhom2), as the underlying cause of TOC. We show that the distribution of RHBDF2 in tylotic skin is altered in comparison with that in normal skin, and immortalized tylotic keratinocytes have decreased levels of total epidermal growth factor receptor (EGFR) and display an increased proliferative and migratory potential relative to normal cells, even when normal cells are stimulated with exogenous epidermal growth factor. It would thus appear that EGFR signaling is dysregulated in tylotic cells. Furthermore, we also show an altered localization of RHBDF2 in both tylotic and sporadic squamous esophageal tumors. The elucidation of a role of RHBDF2 in growth-factor signaling in esophageal cancer will help to determine whether targeting this pathway in chemotherapy for this and other squamous cell carcinomas will be effective.


Asunto(s)
Neoplasias Esofágicas/genética , Queratodermia Palmar y Plantar Difusa/genética , Mutación Missense , Serina Proteasas/genética , Secuencia de Aminoácidos , Carcinoma de Células Escamosas/genética , Procesos de Crecimiento Celular/genética , Movimiento Celular/genética , Cromosomas Humanos Par 17/genética , Receptores ErbB/genética , Neoplasias Esofágicas/enzimología , Neoplasias Esofágicas/metabolismo , Neoplasias Esofágicas/patología , Exones , Humanos , Queratinocitos/metabolismo , Queratodermia Palmar y Plantar Difusa/enzimología , Queratodermia Palmar y Plantar Difusa/metabolismo , Queratodermia Palmar y Plantar Difusa/patología , Datos de Secuencia Molecular , Linaje , Fenotipo , Alineación de Secuencia , Serina Endopeptidasas , Regiones no Traducidas
2.
Nat Genet ; 37(1): 84-9, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15608640

RESUMEN

Interindividual variability in drug response, ranging from no therapeutic benefit to life-threatening adverse reactions, is influenced by variation in genes that control the absorption, distribution, metabolism and excretion of drugs. We genotyped 904 single-nucleotide polymorphisms (SNPs) from 55 such genes in two population samples (European and Japanese) and identified a set of tagging SNPs that represents the common variation in these genes, both known and unknown. Extensive empirical evaluations, including a direct assessment of association with candidate functional SNPs in a new, larger population sample, validated the performance of these tagging SNPs and confirmed their utility for linkage-disequilibrium mapping in pharmacogenetics. The analyses also suggest that rare variation is not amenable to tagging strategies.


Asunto(s)
Preparaciones Farmacéuticas/metabolismo , Farmacocinética , Polimorfismo de Nucleótido Simple , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Humanos
3.
Trends Genet ; 22(5): 250-2, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16564110

RESUMEN

One of the mantras of scientists working in the field of pharmacogenetics is 'the right dose for the right patient'. A recent article has gone someway towards demonstrating that this goal can be achieved using genetic approaches. It is one of the first reports to show that a specific polymorphism can predict the maximum tolerated dose of two anti-epileptic drugs. However, further studies are necessary to validate these observations.


Asunto(s)
Quimioterapia/métodos , Epilepsia/tratamiento farmacológico , Farmacogenética/métodos , Farmacogenética/tendencias , Polimorfismo Genético , Relación Dosis-Respuesta a Droga , Humanos
4.
Curr Biol ; 13(13): 1129-33, 2003 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-12842012

RESUMEN

We identified two novel mouse mutants with abnormal head-shaking behavior and neural tube defects during the course of independent ENU mutagenesis experiments. The heterozygous and homozygous mutants exhibit defects in the orientation of sensory hair cells in the organ of Corti, indicating a defect in planar cell polarity. The homozygous mutants exhibit severe neural tube defects as a result of failure to initiate neural tube closure. We show that these mutants, spin cycle and crash, carry independent missense mutations within the coding region of Celsr1, encoding a large protocadherin molecule [1]. Celsr1 is one of three mammalian homologs of Drosophila flamingo/starry night, which is essential for the planar cell polarity pathway in Drosophila together with frizzled, dishevelled, prickle, strabismus/van gogh, and rhoA. The identification of mouse mutants of Celsr1 provides the first evidence for the function of the Celsr family in planar cell polarity in mammals and further supports the involvement of a planar cell polarity pathway in vertebrate neurulation.


Asunto(s)
Polaridad Celular/fisiología , Células Ciliadas Auditivas Internas/fisiopatología , Mutación Missense/genética , Defectos del Tubo Neural/fisiopatología , Receptores Acoplados a Proteínas G/genética , Animales , Polaridad Celular/genética , Mapeo Cromosómico , Células Ciliadas Auditivas Internas/ultraestructura , Hibridación in Situ , Ratones , Microscopía Electrónica de Rastreo , Análisis de Secuencia de ADN , Transducción de Señal/fisiología
5.
Nucleic Acids Res ; 31(8): e43, 2003 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-12682378

RESUMEN

We have developed a new method using the Qbead system for high-throughput genotyping of single nucleotide polymorphisms (SNPs). The Qbead system employs fluorescent Qdot semiconductor nanocrystals, also known as quantum dots, to encode microspheres that subsequently can be used as a platform for multiplexed assays. By combining mixtures of quantum dots with distinct emission wavelengths and intensities, unique spectral 'barcodes' are created that enable the high levels of multiplexing required for complex genetic analyses. Here, we applied the Qbead system to SNP genotyping by encoding microspheres conjugated to allele-specific oligonucleotides. After hybridization of oligonucleotides to amplicons produced by multiplexed PCR of genomic DNA, individual microspheres are analyzed by flow cytometry and each SNP is distinguished by its unique spectral barcode. Using 10 model SNPs, we validated the Qbead system as an accurate and reliable technique for multiplexed SNP genotyping. By modifying the types of probes conjugated to microspheres, the Qbead system can easily be adapted to other assay chemistries for SNP genotyping as well as to other applications such as analysis of gene expression and protein-protein interactions. With its capability for high-throughput automation, the Qbead system has the potential to be a robust and cost-effective platform for a number of applications.


Asunto(s)
Análisis Mutacional de ADN/métodos , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo de Nucleótido Simple/genética , ADN/química , ADN/genética , Análisis Mutacional de ADN/instrumentación , Femenino , Genotipo , Humanos , Masculino , Microesferas , Reacción en Cadena de la Polimerasa/instrumentación , Sensibilidad y Especificidad
6.
J Neurosci ; 23(5): 1631-7, 2003 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-12629167

RESUMEN

The robotic mouse is an autosomal dominant mutant that arose from a large-scale chemical mutagenesis program. It has a jerky, ataxic gait and develops adult-onset Purkinje cell loss in the cerebellum in a striking region-specific pattern, as well as cataracts. Genetic and physical mapping of the disease locus led to the identification of a missense mutation in a highly conserved region of Af4, a putative transcription factor that has been previously implicated in leukemogenesis. We demonstrate that Af4 is specifically expressed in Purkinje cells, and we hypothesize that the expression of mutant Af4 leads to neurodegeneration. This function was not identified through knock-out studies, highlighting the power of phenotype-driven mutagenesis in the mouse to identify new pathways involved in neurological disease.


Asunto(s)
Catarata/genética , Ataxia Cerebelosa/genética , Cerebelo/patología , Proteínas de Unión al ADN/genética , Proteínas Nucleares/genética , Células de Purkinje/patología , Secuencia de Aminoácidos , Animales , Antígenos CD/biosíntesis , Recuento de Células , Ataxia Cerebelosa/patología , Secuencia Conservada , Proteínas de Unión al ADN/biosíntesis , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Citometría de Flujo , Genes Dominantes , Ratones , Ratones Mutantes Neurológicos , Datos de Secuencia Molecular , Mutagénesis , Proteínas Nucleares/biosíntesis , Especificidad de Órganos/genética , Mapeo Físico de Cromosoma , Mutación Puntual , Células de Purkinje/metabolismo , Homología de Secuencia de Aminoácido , Timo/metabolismo , Timo/patología
7.
Diabetes ; 53(6): 1577-83, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15161764

RESUMEN

Here we report the first cloned N-ethyl-nitrosourea (ENU)-derived mouse model of diabetes. GENA348 was identified through free-fed plasma glucose measurement, being more than 2 SDs above the population mean of a cohort of >1,201 male ENU mutant mice. The underlying gene was mapped to the maturity-onset diabetes of the young (MODY2) homology region of mouse chromosome 11 (logarithm of odds 6.0). Positional candidate gene analyses revealed an A to T transversion mutation in exon 9 of the glucokinase gene, resulting in an isoleucine to phenylalanine change at amino acid 366 (I366F). Heterozygous mutants have 67% of the enzyme activity of wild-type littermates (P < 0.0012). Homozygous mutants have less enzyme activity (14% of wild-type activity) and are even less glucose tolerant. The GENA348 allele is novel because no mouse or human diabetes studies have described a mutation in the corresponding amino acid position. It is also the first glucokinase missense mutation reported in mice and is homozygous viable, unlike the global knockout mutations. This work demonstrates that ENU mutagenesis screens can be used to generate models of complex phenotypes, such as type 2 diabetes, that are directly relevant to human disease.


Asunto(s)
Diabetes Mellitus Tipo 2/genética , Modelos Animales de Enfermedad , Etilnitrosourea/farmacología , Glucoquinasa/genética , Mutágenos/farmacología , Mutación Missense , Adenina , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Animales , Mapeo Cromosómico , Glucoquinasa/efectos de los fármacos , Glucoquinasa/metabolismo , Glucosa/metabolismo , Intolerancia a la Glucosa/genética , Heterocigoto , Homocigoto , Isoleucina , Masculino , Ratones , Ratones Mutantes , Datos de Secuencia Molecular , Fenilalanina , Fosforilación , Timina
8.
Arterioscler Thromb Vasc Biol ; 22(11): 1924-8, 2002 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-12426226

RESUMEN

OBJECTIVE: Studies in mice have shown that genetic disruption of monocyte chemotactic protein-1 or its receptor, the C-C chemokine receptor 2 (CCR2), inhibits atherosclerosis, but few data exist in humans to suggest that the monocyte chemotactic protein-1-CCR2 interaction is important in atherogenesis. A common polymorphism in the human CCR2 gene resulting in a substitution of isoleucine for valine (Val64Ile) has been associated with other disease phenotypes in humans. METHODS AND RESULTS: A cohort of first-degree relatives of persons with premature coronary artery disease was recruited and quantitatively phenotyped for the extent of CAC, a marker of coronary atherosclerosis, by using electron beam CT. The extent of CAC was significantly lower in subjects with the CCR2-Ile64 variant (Val/Ile and Ile/Ile genotypes) than in subjects carrying 2 Val64 alleles, even after adjustment for traditional risk factors. CONCLUSIONS: This study provides genetic evidence linking CCR2 with coronary atherosclerosis in humans.


Asunto(s)
Calcinosis/genética , Cardiomiopatías/genética , Vasos Coronarios/patología , Isoleucina/genética , Polimorfismo Genético/genética , Receptores de Quimiocina/genética , Valina/genética , Adulto , Anciano , Sustitución de Aminoácidos/genética , Vasos Coronarios/química , Vasos Coronarios/metabolismo , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Receptores CCR2 , Factores Sexuales
9.
Curr Opin Pharmacol ; 3(3): 291-4, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12810195

RESUMEN

The skeleton contains over 200 bones, with the regulation of calcium being vital for maintaining this dynamic tissue. The calcium-sensing receptor (CASR) plays a pivotal role in the regulation of calcium both systemically through the parathyroid and locally in specific tissues. Recent studies have identified several sites of expression and further functions for the CASR gene, which include a role in the epidermis, tooth development and fluid regulation. In addition, genetic studies have identified gain-of-function mutations in the CASR gene, leading to a greater understanding of the pathogenesis of Bartter's syndrome, an inherited nephropathy that results in deficiency of sodium and chloride absorption.


Asunto(s)
Calcio/metabolismo , Receptores Sensibles al Calcio/genética , Síndrome de Bartter/tratamiento farmacológico , Síndrome de Bartter/genética , Síndrome de Bartter/metabolismo , Densidad Ósea/genética , Remodelación Ósea/genética , Ensayos Clínicos como Asunto , Humanos , Mutación , Hormona Paratiroidea/genética , Hormona Paratiroidea/fisiología
10.
J Bone Miner Res ; 19(1): 31-41, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14753734

RESUMEN

UNLABELLED: BMD values in approximately 3000 perimenopausal Scottish women were adjusted by regression to identify and account for nongenetic factors. Adjusted BMD values were not associated with simple tandem repeat (STR) markers or single nucleotide polymorphisms (SNPs) at the Cathepsin K (CTSK) locus. We present a thorough analysis of common CTSK polymorphisms and genetic relatedness among CTSK haplotypes. INTRODUCTION: CTSK is a cysteine protease of the papain family and is thought to play a critical role in osteoclast-mediated bone degradation. Rare, inactivating mutations in CTSK cause pychodysostosis, an autosomal recessive osteochondrodysplasia characterized by osteosclerosis and short stature. However, there have been no studies of common genetic variants in CTSK and their possible association with bone density in the general population. MATERIALS AND METHODS: To identify common single nucleotide polymorphisms (SNPs) and simple tandem repeat (STR) polymorphisms in and around CTSK, we screened all CTSK exons, intron A, all intron-exon boundaries, and the putative CTSK promoter region in 130 random whites using both high-performance liquid chromatography (HPLC) and DNA sequencing. CTSK markers were genotyped in approximately 3000 perimenopausal Scottish women whose hip and spine bone mineral density (BMD) had been measured by DXA. We performed linear regression analysis to identify and adjust for nongenetic predictors of BMD, and adjusted BMD values (regression residuals) were tested for association with individual CTSK markers and haplotypes by ANOVA and the composite haplotype method of Zaykin et al. RESULTS AND CONCLUSIONS: We discovered two intronic SNPs (8% and 9% frequency), but no common exonic SNPs (> 1% frequency), and found that three STRs at the immediate 5' end of the CTSK locus are highly polymorphic. The population frequencies of haplotypes defined by these five polymorphisms were estimated, and a cladogram was derived showing proximity of relationship and likely descent of the 30 most common CTSK haplotypes. Regression analyses revealed that approximately 39% of spine and 19% of hip rate of change in BMD was accounted for by nongenetic factors. For baseline BMD values in premenopausal women, nongenetic predictors explained 11% of the variance at the spine and 13% at the hip. Adjusted BMD values showed no statistically significant association with any of the individual CTSK polymorphisms or CTSK haplotypes.


Asunto(s)
Densidad Ósea , Catepsinas/genética , Climaterio/metabolismo , Polimorfismo Genético/genética , Análisis de Varianza , Estatura , Índice de Masa Corporal , Peso Corporal , Catepsina K , Climaterio/genética , Estudios de Cohortes , Repeticiones de Dinucleótido/genética , Femenino , Cuello Femoral/química , Frecuencia de los Genes , Genotipo , Haplotipos/genética , Terapia de Reemplazo de Hormonas , Humanos , Desequilibrio de Ligamiento/genética , Vértebras Lumbares/química , Persona de Mediana Edad , Polimorfismo Genético/fisiología , Polimorfismo de Nucleótido Simple/genética , Estudios Prospectivos , Análisis de Regresión , Escocia , Factores de Tiempo
11.
Comp Funct Genomics ; 6(5-6): 268-76, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-18629217

RESUMEN

The aryl hydrocarbon receptor nuclear translocator (ARNT) and cathepsin K (CTSK) genes lie in a tandem head-to-tail arrangement on human chromosome 1. The two genes are in extremely close proximity; the usual CTSK transcription start site is less than 1.4 kb downstream of the end of the longest reported ARNT transcript. By generating an RT-PCR product that overlaps both the 3' end of ARNT and the 5' end of CTSK, we show that ARNT transcripts may extend through the ARNT-CTSK intergenic region and progress into the CTSK gene. Furthermore, by using quantitative RT-PCR from several tissues to detect the ARNT expression signature in CTSK introns, we show that ARNT transcripts can read through into CTSK as far as CTSK intron 3, extending approximately 3.7 kb downstream of the end of the longest previously described ARNT mRNA. Given that ARNT and CTSK are expressed in an overlapping range of tissues, ARNT read-through may have a negative impact on CTSK transcript levels by interfering with CTSK expression. We also present evidence for novel CTSK transcripts following sequence analysis of CTSK-derived ESTs and RT-PCR products. These transcripts show alternate 5' splicing and or 5' extension and are sometimes initiated from a cryptic alternative promoter which is upstream of the known CTSK promoter and possibly in the 3' UTR of ARNT.

12.
Hum Mol Genet ; 11(20): 2377-84, 2002 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-12351573

RESUMEN

The molecular mechanisms regulating bone remodelling are only partially understood. One of the controversial issues discussed during the past few years is the role that calcium signalling plays in this process and, in particular, in the functioning of the osteoclast. Calcium is involved in the recruitment and activation of osteoclasts and their subsequent detachment from bone. Parathyroid hormone and vitamin D are part of a systemic mechanism regulating calcium availability, storage and disposal. But there are conflicting results suggesting the presence of a local calcium-sensing mechanism in osteoclasts, in osteoblasts or in both. If this system could be characterized, it would be of therapeutic relevance for diseases such as postmenopausal osteoporosis and rheumatoid arthritis. Genetic data, animal models and cell-based assays have not yet been used to their full extent in this area. Here we review the available data and outline possible future strategies.


Asunto(s)
Huesos/metabolismo , Calcio/metabolismo , Densidad Ósea , Remodelación Ósea , Huesos/citología , Humanos , Osteoblastos/metabolismo , Osteoclastos/metabolismo
13.
J Neurocytol ; 32(9): 1143-54, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15044845

RESUMEN

The semi-dominantly inherited mouse mutation pardon (Pdo) was isolated due to the lack of a Preyer reflex (ear flick) in response to sound from a large-scale N -ethyl- N -nitrosourea (ENU) mutagenesis programme. Dissection of the middle ear revealed malformations in all three ossicles, rendering the ossicular chain incomplete. Hair cell counts in the apical turn of the organ of Corti revealed a significant 22.7% increase in the number of outer hair cells. Raised compound action potential thresholds in Pdo/+ mutants suggested a combined sensorineural/conductive hearing loss. We show that a missense mutation in the homeobox gene Emx2 is responsible for these defects, identifying a new function for this gene in the development of specific structures in the ear.


Asunto(s)
Cóclea/patología , Oído Medio/patología , Pérdida Auditiva Conductiva/patología , Pérdida Auditiva Sensorineural/patología , Proteínas de Homeodominio/genética , Potenciales de Acción/genética , Animales , Umbral Auditivo/fisiología , Cóclea/anomalías , Cóclea/fisiopatología , Osículos del Oído/anomalías , Osículos del Oído/patología , Osículos del Oído/fisiopatología , Oído Medio/anomalías , Oído Medio/fisiopatología , Femenino , Regulación del Desarrollo de la Expresión Génica/genética , Células Ciliadas Auditivas Externas/anomalías , Células Ciliadas Auditivas Externas/patología , Células Ciliadas Auditivas Externas/fisiopatología , Pérdida Auditiva Conductiva/genética , Pérdida Auditiva Conductiva/fisiopatología , Pérdida Auditiva Sensorineural/genética , Pérdida Auditiva Sensorineural/fisiopatología , Proteínas de Homeodominio/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Mutantes , Microscopía Electrónica de Rastreo , Datos de Secuencia Molecular , Mutación Missense/genética , Homología de Secuencia de Aminoácido , Factores de Transcripción
14.
Comp Funct Genomics ; 5(2): 123-7, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-18629060

RESUMEN

Three mutant mice with pigmentation phenotypes were recovered from a genomewide random mouse chemical mutagenesis study. White toes (Whto; MGI:1861986), Belly spot and white toes (Bswt; MGI:2152776) and Dark footpads 2 (Dfp2; MGI:1861991) were identified following visual inspection of progeny from a male exposed to the point mutagen ethylnitrosourea (ENU). In order to rapidly localize the causative mutations, genome-wide linkage scans were performed on pooled DNA samples from backcross animals for each mutant line. Whto was mapped to proximal mouse chromosome (Mmu) 7 between Cen (the centromere) and D7Mit112 (8.0 cM from the centromere), Bswt was mapped to centric Mmul between D1Mit214 (32.1 cM) and D1Mit480 (32.8 cM) and Dfp2 was mapped to proximalMmu4 between Cen and D4Mit18 (5.2 cM). Whto, Bswt and Dfp2 may provide novel starting points in furthering the elucidation of genetic and biochemical pathways relevant to pigmentation and associated biological processes.

15.
Mamm Genome ; 13(10): 595-602, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12420138

RESUMEN

We used ENU mutagenesis in the mouse for the rapid generation of novel mutant phenotypes for both gene function studies and use as new animal models of human disease (Nolan et al. 2000b). One focus of the program was the development of a blood biochemistry screen. At 8-12 weeks of age, approximately 300 ml of blood was collected from F1 offspring of ENU mutagenized male mice. This yielded approximately 125 ml of plasma, used to perform a profile of 17 standard biochemical tests on an Olympus analyzer. Cohorts of F1 mice were also aged and then retested to detect late onset phenotypes. In total, 1,961 F1s were screened. Outliers were identified by running means and standard deviations. Of 70 mice showing consistent abnormalities in plasma biochemistry, 29 were entered into inheritance testing. Of these, 9 phenotypes were confirmed as inherited, 10 found not to be inherited, and 10 are still being tested. Inherited mutant phenotypes include abnormal lipid profiles (low total and HDL cholesterol, high triglycerides); abnormalities in bone and liver metabolism (low ALP, high ALP, high ALT, and AST); abnormal plasma electrolyte levels (high sodium and chloride); as well as phenotypes of interest for the study of diabetes (high glucose). The gene loci bearing the mutations are currently being mapped and further characterized. Our results have validated our biochemical screen, which is applicable to other mutagenesis projects, and we have produced a new set of mutants with defined metabolic phenotypes.


Asunto(s)
Fenotipo , Plasma/química , Animales , Modelos Animales de Enfermedad , Etilnitrosourea/farmacología , Femenino , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Mutantes , Mutagénesis
16.
Mamm Genome ; 15(8): 585-91, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15457338

RESUMEN

N-ethyl-N-nitrosourea (ENU) introduces mutations throughout the mouse genome at relatively high efficiency. Successful high-throughput phenotype screens have been reported and alternative screens using sequence-based approaches have been proposed. For the purpose of generating an allelic series in selected genes by a sequence-based approach, we have constructed an archive of over 4000 DNA samples from individual F1 ENU-mutagenized mice paralleled by frozen sperm samples. Together with our previously reported archive, the total size now exceeds 6000 individuals. A gene-based screen of 27.4 Mbp of DNA, carried out using denaturing high-performance liquid chromatography (DHPLC), found a mutation rate of 1 in 1.01 Mbp of which 1 in 1.82 Mbp were potentially functional. Screening of whole or selected regions of genes on subsets of the archive has allowed us to identify 15 new alleles from 9 genes out of 15 tested. This is a powerful adjunct to conventional mutagenesis strategies and has the advantage of generating a variety of alleles with potentially different phenotypic outcomes that facilitate the investigation of gene function. It is now available to academic collaborators as a community resource.


Asunto(s)
Alquilantes/farmacología , Alelos , Etilnitrosourea/farmacología , Mutación , Animales , Cromatografía Líquida de Alta Presión , Análisis Mutacional de ADN , Ratones
17.
Genetica ; 122(1): 47-9, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15619960

RESUMEN

With the completion of the first draft of the human genome sequence, the next major challenge is assigning function to genes. One approach is genome-wide random chemical mutagenesis, followed by screening for mutant phenotypes of interest and subsequent mapping and identification of the mutated genes in question. We (a consortium made up of GlaxoSmithKline, the MRC Mammalian Genetics Unit and Mouse Genome Centre, Harwell, Imperial College, London, and the Royal London Hospital) have used ENU mutagenesis in the mouse for the rapid generation of novel mutant phenotypes for use as animal models of human disease and for gene function assignment (Nolan et al., 2000). As of 2003, 35,000 mice have been produced to date in a genome-wide screen for dominant mutations and screened using a variety of screening protocols. Nearly 200 mutants have been confirmed as heritable and added to the mouse mutant catalogue and, overall, we can extrapolate that we have recovered over 700 mutants from the screening programme. For further information on the project and details of the data, see http://www.mgu.har.mrc.ac.uk/mutabase.


Asunto(s)
Mapeo Cromosómico , Modelos Animales de Enfermedad , Genoma , Ratones/genética , Animales , Mutación , Fenotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA